- 期刊
The Effect of Oral Verapamil on the Visual Evoked Potentials in Multiple Sclerosis Patients
並列摘要
Background & Aims: Ionic channel rearrangements through demyelinated axons or supporting media play a significant role in remission of neurological deficits in multiple sclerosis (MS) patients. The role of calcium channel blockers on the MS demyelination sequels is controversial. We studied the change of visual evoked potential (VEP) P100 induced by verapamil in MS patients. Materials & Methods: We conducted a randomized double blind, placebo controlled, clinical trial on two groups of 20 clinically definite MS patients who had no relapse during the previous one year. Changes in P100 latency were compared between subjects taking 3 dosages of oral verapamil 40 mg, every 8 hours and subjects taking placebo. Results: In the verapamil group, the P100 latencies shortened an average of 6.1±4 ms compare to placebo group 1±0.5 ms (P＜0.05). Verapamil had no significant effect on the VEP duration. Conclusion: The present study suggests pharmacological manipulation of calcium-dependent process, possibly at the level of demyelinated axon, can rapidly facilitate conduction of electrical impulses in visual pathways of stable MS patients.
延伸閱讀
- 林衢序、裴育晟、鍾佳英、鄭寶釵、陳嘉玲、黃美涓（2005）。Event-Related Potentials of Visual Spatial Attention in Healthy Subjects。台灣復健醫學雜誌，33(1)，19-28。https://doi.org/10.6315/2005.33(1)03
- Genç, G., Bek, S., Kasikci, T., Ulas, U. H., Demirkaya, S., & Odabasi, Z. (2012). Strength-Duration Time Constant in Peripheral Nerve: No Abnormality in Multiple Sclerosis. Multiple Sclerosis International, 2012(), 60-65. https://doi.org/10.1155/2012/390157
- 黃玉蓮（2006）。A Clinical Investigation of the Nonverbal Emotional Recognition in Depressed Patients〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2006.02101
- 陳媖足、林育毅、王明泉、李永昌（2017）。The Exploration and Treatment of Stereotypical Behavior in Individuals with Visual Impairment。特殊教育季刊，(143)，11-17。https://doi.org/10.6217/SEQ.2017.143.11-17
- Crooks, J., Gargaro, M., Vacca, C., Volpi, C., Pirro, M., Scalisi, G., Turco, A., Romani, R., Matino, D., Rostami, A., Puccetti, P., Gran, B., & Fallarino, F. (2017). CpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis. Mediators of Inflammation, 2017(), 1-12. https://doi.org/10.1155/2017/1380615